Hepatic Antiviral Drug Market - Global Outlook and Forecast 2022-2028

January 2022 | 66 pages | ID: HC328CBF4F71EN
Market Monitor Global

Abstracts

It is an antiviral drug used to treat hepatitis virus infections.

This report contains market size and forecasts of Hepatic Antiviral Drug in Global, including the following market information:

Global Hepatic Antiviral Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Hepatic Antiviral Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Entecavir Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hepatic Antiviral Drug include Teva Pharmaceutical Industries, Bristol-Myers Squibb, Zydus Cadila, Cipla, Prinston Pharmaceutical, Hetero Drug, Aurobindo Pharma, Apotex and Gilead Sciences and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hepatic Antiviral Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hepatic Antiviral Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Hepatic Antiviral Drug Market Segment Percentages, by Type, 2021 (%)

• Entecavir
• Tenofovir
• lamivudine
• Adefovir
• Telbivudine
• Others

Global Hepatic Antiviral Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Hepatic Antiviral Drug Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Homecare
• Clinics
• Others

Global Hepatic Antiviral Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Hepatic Antiviral Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Hepatic Antiviral Drug revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Hepatic Antiviral Drug revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Teva Pharmaceutical Industries
• Bristol-Myers Squibb
• Zydus Cadila
• Cipla
• Prinston Pharmaceutical
• Hetero Drug
• Aurobindo Pharma
• Apotex
• Gilead Sciences
• Mylan

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Hepatic Antiviral Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Hepatic Antiviral Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HEPATIC ANTIVIRAL DRUG OVERALL MARKET SIZE

2.1 Global Hepatic Antiviral Drug Market Size: 2021 VS 2028
2.2 Global Hepatic Antiviral Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Hepatic Antiviral Drug Players in Global Market
3.2 Top Global Hepatic Antiviral Drug Companies Ranked by Revenue
3.3 Global Hepatic Antiviral Drug Revenue by Companies
3.4 Top 3 and Top 5 Hepatic Antiviral Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hepatic Antiviral Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hepatic Antiviral Drug Players in Global Market
  3.6.1 List of Global Tier 1 Hepatic Antiviral Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Hepatic Antiviral Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Hepatic Antiviral Drug Market Size Markets, 2021 & 2028
  4.1.2 Entecavir
  4.1.3 Tenofovir
  4.1.4 lamivudine
  4.1.5 Adefovir
  4.1.6 Telbivudine
  4.1.7 Others
4.2 By Type - Global Hepatic Antiviral Drug Revenue & Forecasts
  4.2.1 By Type - Global Hepatic Antiviral Drug Revenue, 2017-2022
  4.2.2 By Type - Global Hepatic Antiviral Drug Revenue, 2023-2028
  4.2.3 By Type - Global Hepatic Antiviral Drug Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Hepatic Antiviral Drug Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Homecare
  5.1.4 Clinics
  5.1.5 Others
5.2 By Application - Global Hepatic Antiviral Drug Revenue & Forecasts
  5.2.1 By Application - Global Hepatic Antiviral Drug Revenue, 2017-2022
  5.2.2 By Application - Global Hepatic Antiviral Drug Revenue, 2023-2028
  5.2.3 By Application - Global Hepatic Antiviral Drug Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Hepatic Antiviral Drug Market Size, 2021 & 2028
6.2 By Region - Global Hepatic Antiviral Drug Revenue & Forecasts
  6.2.1 By Region - Global Hepatic Antiviral Drug Revenue, 2017-2022
  6.2.2 By Region - Global Hepatic Antiviral Drug Revenue, 2023-2028
  6.2.3 By Region - Global Hepatic Antiviral Drug Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Hepatic Antiviral Drug Revenue, 2017-2028
  6.3.2 US Hepatic Antiviral Drug Market Size, 2017-2028
  6.3.3 Canada Hepatic Antiviral Drug Market Size, 2017-2028
  6.3.4 Mexico Hepatic Antiviral Drug Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Hepatic Antiviral Drug Revenue, 2017-2028
  6.4.2 Germany Hepatic Antiviral Drug Market Size, 2017-2028
  6.4.3 France Hepatic Antiviral Drug Market Size, 2017-2028
  6.4.4 U.K. Hepatic Antiviral Drug Market Size, 2017-2028
  6.4.5 Italy Hepatic Antiviral Drug Market Size, 2017-2028
  6.4.6 Russia Hepatic Antiviral Drug Market Size, 2017-2028
  6.4.7 Nordic Countries Hepatic Antiviral Drug Market Size, 2017-2028
  6.4.8 Benelux Hepatic Antiviral Drug Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Hepatic Antiviral Drug Revenue, 2017-2028
  6.5.2 China Hepatic Antiviral Drug Market Size, 2017-2028
  6.5.3 Japan Hepatic Antiviral Drug Market Size, 2017-2028
  6.5.4 South Korea Hepatic Antiviral Drug Market Size, 2017-2028
  6.5.5 Southeast Asia Hepatic Antiviral Drug Market Size, 2017-2028
  6.5.6 India Hepatic Antiviral Drug Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Hepatic Antiviral Drug Revenue, 2017-2028
  6.6.2 Brazil Hepatic Antiviral Drug Market Size, 2017-2028
  6.6.3 Argentina Hepatic Antiviral Drug Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Hepatic Antiviral Drug Revenue, 2017-2028
  6.7.2 Turkey Hepatic Antiviral Drug Market Size, 2017-2028
  6.7.3 Israel Hepatic Antiviral Drug Market Size, 2017-2028
  6.7.4 Saudi Arabia Hepatic Antiviral Drug Market Size, 2017-2028
  6.7.5 UAE Hepatic Antiviral Drug Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Teva Pharmaceutical Industries
  7.1.1 Teva Pharmaceutical Industries Corporate Summary
  7.1.2 Teva Pharmaceutical Industries Business Overview
  7.1.3 Teva Pharmaceutical Industries Hepatic Antiviral Drug Major Product Offerings
  7.1.4 Teva Pharmaceutical Industries Hepatic Antiviral Drug Revenue in Global Market (2017-2022)
  7.1.5 Teva Pharmaceutical Industries Key News
7.2 Bristol-Myers Squibb
  7.2.1 Bristol-Myers Squibb Corporate Summary
  7.2.2 Bristol-Myers Squibb Business Overview
  7.2.3 Bristol-Myers Squibb Hepatic Antiviral Drug Major Product Offerings
  7.2.4 Bristol-Myers Squibb Hepatic Antiviral Drug Revenue in Global Market (2017-2022)
  7.2.5 Bristol-Myers Squibb Key News
7.3 Zydus Cadila
  7.3.1 Zydus Cadila Corporate Summary
  7.3.2 Zydus Cadila Business Overview
  7.3.3 Zydus Cadila Hepatic Antiviral Drug Major Product Offerings
  7.3.4 Zydus Cadila Hepatic Antiviral Drug Revenue in Global Market (2017-2022)
  7.3.5 Zydus Cadila Key News
7.4 Cipla
  7.4.1 Cipla Corporate Summary
  7.4.2 Cipla Business Overview
  7.4.3 Cipla Hepatic Antiviral Drug Major Product Offerings
  7.4.4 Cipla Hepatic Antiviral Drug Revenue in Global Market (2017-2022)
  7.4.5 Cipla Key News
7.5 Prinston Pharmaceutical
  7.5.1 Prinston Pharmaceutical Corporate Summary
  7.5.2 Prinston Pharmaceutical Business Overview
  7.5.3 Prinston Pharmaceutical Hepatic Antiviral Drug Major Product Offerings
  7.5.4 Prinston Pharmaceutical Hepatic Antiviral Drug Revenue in Global Market (2017-2022)
  7.5.5 Prinston Pharmaceutical Key News
7.6 Hetero Drug
  7.6.1 Hetero Drug Corporate Summary
  7.6.2 Hetero Drug Business Overview
  7.6.3 Hetero Drug Hepatic Antiviral Drug Major Product Offerings
  7.6.4 Hetero Drug Hepatic Antiviral Drug Revenue in Global Market (2017-2022)
  7.6.5 Hetero Drug Key News
7.7 Aurobindo Pharma
  7.7.1 Aurobindo Pharma Corporate Summary
  7.7.2 Aurobindo Pharma Business Overview
  7.7.3 Aurobindo Pharma Hepatic Antiviral Drug Major Product Offerings
  7.7.4 Aurobindo Pharma Hepatic Antiviral Drug Revenue in Global Market (2017-2022)
  7.7.5 Aurobindo Pharma Key News
7.8 Apotex
  7.8.1 Apotex Corporate Summary
  7.8.2 Apotex Business Overview
  7.8.3 Apotex Hepatic Antiviral Drug Major Product Offerings
  7.8.4 Apotex Hepatic Antiviral Drug Revenue in Global Market (2017-2022)
  7.8.5 Apotex Key News
7.9 Gilead Sciences
  7.9.1 Gilead Sciences Corporate Summary
  7.9.2 Gilead Sciences Business Overview
  7.9.3 Gilead Sciences Hepatic Antiviral Drug Major Product Offerings
  7.9.4 Gilead Sciences Hepatic Antiviral Drug Revenue in Global Market (2017-2022)
  7.9.5 Gilead Sciences Key News
7.10 Mylan
  7.10.1 Mylan Corporate Summary
  7.10.2 Mylan Business Overview
  7.10.3 Mylan Hepatic Antiviral Drug Major Product Offerings
  7.10.4 Mylan Hepatic Antiviral Drug Revenue in Global Market (2017-2022)
  7.10.5 Mylan Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Hepatic Antiviral Drug Market Opportunities & Trends in Global Market
Table 2. Hepatic Antiviral Drug Market Drivers in Global Market
Table 3. Hepatic Antiviral Drug Market Restraints in Global Market
Table 4. Key Players of Hepatic Antiviral Drug in Global Market
Table 5. Top Hepatic Antiviral Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Hepatic Antiviral Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Hepatic Antiviral Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Hepatic Antiviral Drug Product Type
Table 9. List of Global Tier 1 Hepatic Antiviral Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hepatic Antiviral Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Hepatic Antiviral Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Hepatic Antiviral Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Hepatic Antiviral Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Hepatic Antiviral Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Hepatic Antiviral Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Hepatic Antiviral Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Hepatic Antiviral Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Hepatic Antiviral Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Hepatic Antiviral Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Hepatic Antiviral Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Hepatic Antiviral Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Hepatic Antiviral Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Hepatic Antiviral Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Hepatic Antiviral Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Hepatic Antiviral Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Hepatic Antiviral Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Hepatic Antiviral Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Hepatic Antiviral Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Hepatic Antiviral Drug Revenue, (US$, Mn), 2023-2028
Table 30. Teva Pharmaceutical Industries Corporate Summary
Table 31. Teva Pharmaceutical Industries Hepatic Antiviral Drug Product Offerings
Table 32. Teva Pharmaceutical Industries Hepatic Antiviral Drug Revenue (US$, Mn), (2017-2022)
Table 33. Bristol-Myers Squibb Corporate Summary
Table 34. Bristol-Myers Squibb Hepatic Antiviral Drug Product Offerings
Table 35. Bristol-Myers Squibb Hepatic Antiviral Drug Revenue (US$, Mn), (2017-2022)
Table 36. Zydus Cadila Corporate Summary
Table 37. Zydus Cadila Hepatic Antiviral Drug Product Offerings
Table 38. Zydus Cadila Hepatic Antiviral Drug Revenue (US$, Mn), (2017-2022)
Table 39. Cipla Corporate Summary
Table 40. Cipla Hepatic Antiviral Drug Product Offerings
Table 41. Cipla Hepatic Antiviral Drug Revenue (US$, Mn), (2017-2022)
Table 42. Prinston Pharmaceutical Corporate Summary
Table 43. Prinston Pharmaceutical Hepatic Antiviral Drug Product Offerings
Table 44. Prinston Pharmaceutical Hepatic Antiviral Drug Revenue (US$, Mn), (2017-2022)
Table 45. Hetero Drug Corporate Summary
Table 46. Hetero Drug Hepatic Antiviral Drug Product Offerings
Table 47. Hetero Drug Hepatic Antiviral Drug Revenue (US$, Mn), (2017-2022)
Table 48. Aurobindo Pharma Corporate Summary
Table 49. Aurobindo Pharma Hepatic Antiviral Drug Product Offerings
Table 50. Aurobindo Pharma Hepatic Antiviral Drug Revenue (US$, Mn), (2017-2022)
Table 51. Apotex Corporate Summary
Table 52. Apotex Hepatic Antiviral Drug Product Offerings
Table 53. Apotex Hepatic Antiviral Drug Revenue (US$, Mn), (2017-2022)
Table 54. Gilead Sciences Corporate Summary
Table 55. Gilead Sciences Hepatic Antiviral Drug Product Offerings
Table 56. Gilead Sciences Hepatic Antiviral Drug Revenue (US$, Mn), (2017-2022)
Table 57. Mylan Corporate Summary
Table 58. Mylan Hepatic Antiviral Drug Product Offerings
Table 59. Mylan Hepatic Antiviral Drug Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Hepatic Antiviral Drug Segment by Type in 2021
Figure 2. Hepatic Antiviral Drug Segment by Application in 2021
Figure 3. Global Hepatic Antiviral Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hepatic Antiviral Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hepatic Antiviral Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hepatic Antiviral Drug Revenue in 2021
Figure 8. By Type - Global Hepatic Antiviral Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Hepatic Antiviral Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Hepatic Antiviral Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Hepatic Antiviral Drug Revenue Market Share, 2017-2028
Figure 12. US Hepatic Antiviral Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Hepatic Antiviral Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Hepatic Antiviral Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Hepatic Antiviral Drug Revenue Market Share, 2017-2028
Figure 16. Germany Hepatic Antiviral Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Hepatic Antiviral Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Hepatic Antiviral Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Hepatic Antiviral Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Hepatic Antiviral Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Hepatic Antiviral Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Hepatic Antiviral Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Hepatic Antiviral Drug Revenue Market Share, 2017-2028
Figure 24. China Hepatic Antiviral Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Hepatic Antiviral Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Hepatic Antiviral Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Hepatic Antiviral Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Hepatic Antiviral Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Hepatic Antiviral Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Hepatic Antiviral Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Hepatic Antiviral Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Hepatic Antiviral Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Hepatic Antiviral Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Hepatic Antiviral Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Hepatic Antiviral Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Hepatic Antiviral Drug Revenue, (US$, Mn), 2017-2028
Figure 37. Teva Pharmaceutical Industries Hepatic Antiviral Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bristol-Myers Squibb Hepatic Antiviral Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Zydus Cadila Hepatic Antiviral Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Cipla Hepatic Antiviral Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Prinston Pharmaceutical Hepatic Antiviral Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Hetero Drug Hepatic Antiviral Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Aurobindo Pharma Hepatic Antiviral Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Apotex Hepatic Antiviral Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Gilead Sciences Hepatic Antiviral Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Mylan Hepatic Antiviral Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)